Wang Hongli, Chen Wenjie, Jiang Jianyuan, Lu Feizhou, Ma Xiaosheng, Xia Xinlei
Department of Orthopaedics, Huashan Hospital, Fudan University, Shanghai, 200040, China.
BMC Musculoskelet Disord. 2016 Jan 12;17:9. doi: 10.1186/s12891-016-0866-5.
Selecting an interbody cage with appropriate height is one of the key steps in lumbar interbody fusion, and has an important impact on clinical efficacy. How to choose the appropriate height of the cage becomes one of the core problems of lumbar interbody fusion for spine surgeons. However, studies about objective selection criteria on interbody cage height was rare.
One hundred fifty-seven patients with single segment lumbar degenerative diseases treated by TLIF surgery from January 2011 to July 2013 were retrospectively analyzed. Parameters analyzed included: gender, age, body height, clinical diagnosis, pathological segment location and the intervertebral height of pathological segment, pathological segment activity, the intervertebral height of the adjacent segments. And further to analyze the correlation between these parameters and interbody cage height. By measuring the intervertebral height of pathological segment and normal segment to calculate the regression equation of interbody cage height.
The average interbody cage height of male patients (12.38 ± 1.43) mm was significantly higher than female (11.62 ± 1.45) mm (p < 0.001). The L4-5 segment interbody cage height (12.11 ± 1.38) mm was significantly greater than the L5-S1 (11.25 ± 1.32) mm (p = 0.04). Body height, the intervertebral height of pathological segment, and the middle intervertebral heigh of upper adjacent segment were highly positively correlated to the interbody cage height. The range of interbody cage height used in transforaminal lumbar interbody fusion for Chinese patients with lumbar degenerative diseases was: L3-4 (11.28 ± 3.29) mm ~ (12.76 ± 2.40) mm, L4-5 (11.62 ± 2.89) mm ~ (13.18 ± 1.91) mm, L5-S1 (10.52 ± 2.22) mm ~ (11.90 ± 2.80) mm. The regression equation of interbody cage height was: interbody cage height = 11.123-0.563 * (gender) + 0.149 * (the middle intervertebral height of pathological segment).
The selection of interbody cage height was influenced by sex, body height, pathological segment location, the intervertebral height of pathological segment and other factors. The interbody cage height for the lower lumbar spine mostly selected 11,12,13 mm, L3-4, L4-5 segment highly selective in general should not be less than 10 mm, and L5-S1 segments height was relatively small, usually not more than 13 mm. The interbody cage height might be selected based on the regression equation of interbody cage height. But, the regression equation maybe need to be verified in a prospective study.
选择合适高度的椎间融合器是腰椎椎间融合术的关键步骤之一,对临床疗效有重要影响。如何选择合适的椎间融合器高度成为脊柱外科医生进行腰椎椎间融合术的核心问题之一。然而,关于椎间融合器高度客观选择标准的研究较少。
回顾性分析2011年1月至2013年7月接受经椎间孔腰椎椎间融合术(TLIF)治疗的157例单节段腰椎退行性疾病患者。分析的参数包括:性别、年龄、身高、临床诊断、病变节段位置及病变节段的椎间高度、病变节段活动度、相邻节段的椎间高度。并进一步分析这些参数与椎间融合器高度之间的相关性。通过测量病变节段和正常节段的椎间高度来计算椎间融合器高度的回归方程。
男性患者椎间融合器平均高度(12.38±1.43)mm显著高于女性(11.62±1.45)mm(p<0.001)。L4-5节段椎间融合器高度(12.11±1.38)mm显著大于L5-S1节段(11.25±1.32)mm(p = 0.04)。身高、病变节段的椎间高度以及上相邻节段的中间椎间高度与椎间融合器高度呈高度正相关。中国腰椎退行性疾病患者经椎间孔腰椎椎间融合术中使用的椎间融合器高度范围为:L3-4(11.28±3.29)mm~(12.76±2.40)mm,L4-5(11.62±2.89)mm~(13.18±1.91)mm,L5-S1(10.52±2.22)mm~(11.90±2.80)mm。椎间融合器高度的回归方程为:椎间融合器高度 = 11.123 - 0.563×(性别)+ 0.149×(病变节段的中间椎间高度)。
椎间融合器高度的选择受性别、身高、病变节段位置、病变节段的椎间高度等因素影响。下腰椎椎间融合器高度大多选择11、12、13mm,L3-4、L4-5节段一般高度选择通常不应小于10mm,而L5-S1节段高度相对较小通常不超过13mm。可根据椎间融合器高度的回归方程选择椎间融合器高度。但是,该回归方程可能需要在前瞻性研究中进行验证。